EC-359

N/A

Report date: 2025/11/18 14:49:23
NME

Base Information

Drug NameEC-359
Drug Alias NameEC-359
ClassificationSmall molecules > Steroids
Mechanisms of ActionLeukemia inhibitory factor receptor antagonists
TargetsLeukemia inhibitory factor receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvestra
China Registration ClassN/A

Develop Information

Active CompaniesEvestra
Inactive CompaniesEvestra Inc
Active IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Neoplasms +[5] 
Inactive IndicationsTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A